BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

PFM Health Sciences, LP's Holding History (CIK: 0001442756)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 15,000,000 Value ($000) $14,914 Avg Close — Range —
Q1 2024
Shares 15,000,000 Value ($000) $14,766 Avg Close — Range —
Q4 2023
Shares 15,000,000 Value ($000) $14,822 Avg Close — Range —
Q3 2023
Shares 15,000,000 Value ($000) $14,588 Avg Close — Range —
Q2 2023
Shares 15,000,000 Value ($000) $14,772 Avg Close — Range —
Q1 2023
Shares 15,000,000 Value ($000) $15,427 Avg Close — Range —
Q4 2022
Shares 35,910,000 Value ($000) $38,201 Avg Close — Range —
Q3 2022
Shares 45,910,000 Value ($000) $45,604 Avg Close — Range —
Q2 2022
Shares 45,910,000 Value ($000) $45,566 Avg Close — Range —
Q1 2022
Shares 45,910,000 Value ($000) $46,002 Avg Close — Range —
Q4 2021
Shares 45,910,000 Value ($000) $48,118 Avg Close — Range —
Q3 2021
Shares 45,910,000 Value ($000) $47,675 Avg Close — Range —
Q2 2021
Shares 45,910,000 Value ($000) $47,834 Avg Close — Range —
Q1 2021
Shares 45,910,000 Value ($000) $47,356 Avg Close — Range —
Q4 2020
Shares 40,300,000 Value ($000) $43,210 Avg Close — Range —
Q3 2020
Shares 40,300,000 Value ($000) $42,361 Avg Close — Range —
Q2 2020
Shares 41,600,000 Value ($000) $51,199 Avg Close — Range —
Q1 2020
Shares 41,600,000 Value ($000) $43,421 Avg Close — Range —